H. pylori Treatment Regimens and Dosages
Bismuth quadruple therapy for 14 days is the preferred first-line treatment for H. pylori infection, consisting of a PPI twice daily, bismuth subsalicylate 524 mg (or 262 mg as 2 tablets) four times daily, metronidazole 500 mg three to four times daily (total 1.5-2 g daily), and tetracycline 500 mg four times daily. 1, 2, 3
First-Line Treatment Options
Bismuth Quadruple Therapy (Preferred)
- PPI (high-dose): Esomeprazole or rabeprazole 40 mg twice daily, taken 30 minutes before meals on an empty stomach 1, 2
- Bismuth subsalicylate: 524 mg four times daily (or 262 mg as 2 tablets four times daily) 1, 3
- Metronidazole: 500 mg three to four times daily (total daily dose 1.5-2 g) 1, 2, 3
- Tetracycline: 500 mg four times daily 1, 2
- Duration: 14 days (mandatory to maximize eradication rates of 80-90%) 1, 2, 4
This regimen is preferred because bacterial resistance to bismuth is extremely rare, and it achieves high eradication rates even against strains resistant to clarithromycin and metronidazole. 1, 2, 3
Alternative First-Line: Concomitant Non-Bismuth Quadruple Therapy
- PPI (high-dose): Twice daily 1, 2
- Amoxicillin: 1000 mg twice daily 1, 2, 5
- Clarithromycin: 500 mg twice daily 1, 2
- Metronidazole: 500 mg twice daily 1, 2
- Duration: 14 days 1, 2
This regimen should only be used when bismuth is unavailable, as it includes clarithromycin which has increasing resistance rates globally (>15-20% in most regions). 1, 2
Triple Therapy (Only in Low Clarithromycin Resistance Areas <15%)
- PPI (high-dose): Twice daily 1, 2
- Amoxicillin: 1000 mg twice daily 1, 2, 5
- Clarithromycin: 500 mg twice daily 1, 2
- Duration: 14 days 1, 2
Critical caveat: This regimen should be abandoned in most North American and European regions where clarithromycin resistance now exceeds 15%, as eradication rates drop to only 20% with resistant strains compared to 90% with susceptible strains. 1, 2
Second-Line Treatment After First-Line Failure
If Bismuth Quadruple Therapy Not Previously Used
Levofloxacin Triple Therapy (If No Prior Fluoroquinolone Exposure)
- PPI (high-dose): Twice daily 1, 2
- Amoxicillin: 1000 mg twice daily 1, 2, 5
- Levofloxacin: 500 mg once daily OR 250 mg twice daily 1, 2
- Duration: 14 days 1, 2
Important warning: Levofloxacin resistance rates are rising (11-30% primary, 19-30% secondary), and the FDA recommends fluoroquinolones be used as a last choice due to serious side effects. 1, 2
Third-Line and Rescue Therapies
Rifabutin Triple Therapy
- PPI (high-dose): Twice daily 1, 2
- Amoxicillin: 1000 mg twice daily 1, 2, 5
- Rifabutin: 150 mg twice daily 1, 2
- Duration: 14 days 1, 2
Rifabutin resistance is extremely rare, making this an effective rescue option after multiple treatment failures. 1, 2
High-Dose Dual Amoxicillin-PPI Therapy
- Amoxicillin: 2-3 grams daily in 3-4 divided doses 1, 2
- PPI (high-dose): Double standard dose, twice daily 1, 2
- Duration: 14 days 1, 2
This is reserved for patients who have exhausted other options. 1, 2
After Two Failed Attempts
- Antibiotic susceptibility testing should guide further treatment whenever possible 1, 2, 4
- Molecular testing for clarithromycin and levofloxacin resistance can guide therapy selection earlier 1
FDA-Approved Regimens for H. pylori (Adults)
Triple Therapy with Lansoprazole
- Amoxicillin: 1 gram twice daily (every 12 hours) 5
- Clarithromycin: 500 mg twice daily 5
- Lansoprazole: 30 mg twice daily 5
- Duration: 14 days 5
Dual Therapy with Lansoprazole
- Amoxicillin: 1 gram three times daily (every 8 hours) 5
- Lansoprazole: 30 mg three times daily 5
- Duration: 14 days 5
Critical Optimization Factors
PPI Dosing
- Always use high-dose PPI twice daily (not standard once-daily dosing), as this increases cure rates by 6-12% 1, 2
- Esomeprazole or rabeprazole 40 mg twice daily are preferred over other PPIs, increasing cure rates by an additional 8-12% 1, 2
- Take 30 minutes before meals on an empty stomach, without concomitant antacids 1, 2
Treatment Duration
- 14 days is mandatory for all regimens, as it improves eradication success by approximately 5% compared to 7-10 day regimens 1, 2, 4
Antibiotic Selection
- Never repeat antibiotics that failed previously, especially clarithromycin and levofloxacin, where resistance develops rapidly after exposure 1, 2
- Amoxicillin and tetracycline can be re-used because resistance remains rare (<5%) 1, 2
- Metronidazole can be re-used with bismuth because bismuth's synergistic effect overcomes in vitro resistance 1, 2
Special Populations
Penicillin Allergy
- Bismuth quadruple therapy is the first choice, as it contains tetracycline, not amoxicillin 1, 2
- Consider penicillin allergy testing to delist the allergy and enable amoxicillin use 1, 2
Renal Impairment (Amoxicillin Dosing)
- GFR 10-30 mL/min: 500 mg or 250 mg every 12 hours 5
- GFR <10 mL/min: 500 mg or 250 mg every 24 hours 5
- Hemodialysis: 500 mg or 250 mg every 24 hours, with additional dose during and at end of dialysis 5
Pediatric Patients (>3 months, <40 kg)
- Amoxicillin: 45 mg/kg/day in divided doses every 12 hours (or 40 mg/kg/day every 8 hours) for severe infections 5
- Avoid fluoroquinolones and tetracyclines in children 2
- Treatment should only be conducted by pediatricians in specialist centers 1
Verification of Eradication
- Confirm eradication with urea breath test or monoclonal stool antigen test at least 4 weeks after completion of therapy and at least 2 weeks after PPI discontinuation 1, 2, 4
- Never use serology to confirm eradication, as antibodies persist long after successful treatment 1, 2
Common Pitfalls to Avoid
- Inadequate PPI dosing: Standard once-daily PPI is inadequate; always use twice-daily high-dose PPI 1, 2
- Assuming low clarithromycin resistance: Most regions now have resistance >15-20%; do not use triple therapy empirically without local surveillance data 1, 2
- Repeating failed antibiotics: Avoid re-using clarithromycin or levofloxacin after exposure, as cross-resistance is universal 1, 2
- Short treatment duration: 7-10 day regimens are inferior; always use 14 days 1, 2, 4
Adjunctive Measures
- Probiotics can reduce antibiotic-associated diarrhea (occurs in 21-41% of patients) and improve compliance, though evidence for increasing eradication rates is limited 1, 2, 6
- Smoking cessation should be encouraged, as smoking increases eradication failure risk (OR 1.95) 1
- Address compliance issues, as >10% of patients are poor compliers, leading to much lower eradication rates 1